| Financial Year |
March 31 2023 |
| Monetary Funds |
63,319,385.58 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
38,685,156.76 |
| Accounts Receivable |
223,582,966.10 |
| Advances to Suppliers |
12,524,399.56 |
| Other Receivables |
5,080,763.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
220,490,092.29 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
650,604.37 |
| Other Current Assets |
4,251,905.15 |
| Total Current Assets |
578,116,738.09 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
159,730.67 |
| Long-term Equity Investment |
985,185.72 |
| Investment Properties |
59,931,010.94 |
| Fixed Assetes |
336,710,290.30 |
| Under-construction Projects |
624,203.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
59,071,891.23 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
28,756,277.62 |
| Deferred Income Tax Assets |
9,569,068.75 |
| Other Non-Current Assets |
10,050,205.28 |
| Sub-Total of Non-Current Assets |
509,287,234.88 |
| Total Assets |
1,087,403,972.97 |
| Short-Term Loans |
208,225,163.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
44,232,174.12 |
| Accounts Payable |
133,368,191.34 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,665,488.95 |
| Taxes Payable |
5,718,792.36 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,625,652.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,393,358.08 |
| Other Current Liabilities |
867,572.07 |
| Sub-Total of Current Liabilities |
427,151,535.96 |
| Long-term Loans |
75,000,000.00 |
| Bonds Payable |
36,546,899.75 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,304,517.33 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
128,050,478.67 |
| Total Liabilities |
555,202,014.63 |
| Paid-In Capital(Or Share Stock) |
222,122,602.00 |
| Capital Surplus |
114,826,360.80 |
| Surplus Reserve |
25,791,646.46 |
| LESS:Treasury Stock |
3,005,810.31 |
| Undistributed Profits |
165,136,575.25 |
| Minority Stockholder's Interest |
863,095.51 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
531,338,862.83 |
| Owner's Equity（Stockholder's Equity） |
532,201,958.34 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,087,403,972.97 |
